Immune Checkpoint Inhibitor-Associated Sarcoidosis Is Usually a Benign Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation
Eur. J. Cancer 2021 Aug 25;[EPub Ahead of Print], N Chanson, M Ramos-Casals, X Pundole, K Suijkerbuik, M José de Barros E Silva, M Lidar, K Benesova, J Leipe, N Acar-Denizli, P Pradère, JM Michot, AL Voisin, ME Suárez-Almazor, TRD Radstake, V Fernandes Moça Trevisani, H Schulze-Koops, A Melin, C Robert, X Mariette, RP Baughman, O LambotteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.